Perindopril vs Ramipril for Persistence in MAU Reduction Study
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The investigators conducted a single center study controlled study involving 20 patients with
Type 2 Diabetes and hypertension who were randomly assigned to receive ramipril 10mg or
perindopril 8mg. The primary endpoint was difference in urine albumin-creatinine ratio at
night time and during the day. Secondary endpoint was measurement of blood pressure.